• MRI Choice to Detect Bone Mets Varies by Cancer

    Updated: 2012-08-31 14:35:33
    Detection of bone metastases in patients with prostate cancer or myeloma improved significantly with diffusion-weighted MRI as compared with short-tau inversion recovery imaging, British investigators reported.

  • Young Brits’ risky sun habits could increase risk of skin cancer

    Updated: 2012-08-31 00:02:00
    More than a third of 16-24 year olds admit to risky behaviour in the sun, according to a new survey from Cancer Research UK's Made in the Shade campaign.

  • What does the Affordable Care Act have to offer men?

    Updated: 2012-08-30 20:02:43
    By: Theresa Morrow As a wife, a daughter and a mother of a son I often worry about the health of the men in my life. And to be candid, I find myself worrying about the whole future of men’s health in this country. The Affordable Care Act of 2010, has a lot of great [...] Related posts: The Affordable Care Act & How It Affects You

  • 18,500 patients receive treatment through Cancer Drugs Fund

    Updated: 2012-08-30 09:31:00
    A temporary government scheme has allowed thousands of cancer patients in England to receive drugs that are not available on the NHS, according to new figures released today.

  • Early Access Program Needs Your Help – Share Your Experiences to Insure A Continuing Program

    Updated: 2012-08-27 18:20:49
    Dr. Moyad has been the driving force behind getting the Early Access Program for drugs to treat advanced prostate cancer.  Along with the Early Access Committee he has arranged for an early access (before the formal approval from the FDA) for both Zytiga and now MDV3100.  (you can read about the programs including how to [...]

  • PSA Gets Partial Credit for Survival Benefit

    Updated: 2012-08-23 19:29:18
    Overall survival in metastatic prostate cancer improved significantly after the introduction of prostate-specific antigen screening, particularly among black men, a retrospective comparison of three larger clinical trials showed.

  • Experimental ‘stapled peptide’ drug blocks key cancer molecule

    Updated: 2012-08-23 11:26:00
    US scientists have developed an artificial molecule called a ‘stapled peptide’ that can shut down the cancer-fuelling effects of a molecule called Wnt.

  • NICE says 'no' to Avastin for advanced breast cancer

    Updated: 2012-08-22 00:01:00
    The National Institute for Health and Clinical Excellence (NICE) has published new guidance on the use of bevacizumab, better known as Avastin, as a treatment for breast cancer that has spread.

  • Travel Notice

    Updated: 2012-08-20 08:06:49
    I wanted to let everyone know that over the next two weeks my posts might become few and far between. Iaa am traveling with my family in Alaska where my ability to find either internet or cell connections has become difficult. I will attempt to find an occasional connection and put something up. I will [...]

  • Four New Sites Added to the MDV3100 (Enzalutamide) Early Access Trial

    Updated: 2012-08-20 07:42:41
    The Early/Expanded Access Committee has informed me that four additional sites have been added to the trial so there are now 23 States that have an expanded access trial of MDV3100 available to men with advanced prostate cancer. The trial is designed to monitor the safety of the drug in men with progressive castration-resistant advanced [...]

  • So, You Think You Are Safe in Your Doctor’s Office?

    Updated: 2012-08-18 01:16:04
    When the press discusses medical mistakes they are usually referring to mistakes made in a hospital, but guess what, mistakes are often made in a doctors office. These mistakes are not counted in the statistics often quoted. Twelve year old data from the Institute of Medicine sites the horrific statistic that each year between 44,000 [...]

  • PodMed: A Medical News Roundup from Johns Hopkins

    Updated: 2012-08-17 18:30:00
    This week's topics include aspirin and cancer mortality, medical tests on the day of hospital discharge, PSA testing and quality of life, and stroke, bleeding risk, chronic kidney disease, and atrial fibrillation.

  • 852 million people use tobacco products worldwide

    Updated: 2012-08-17 17:24:00
    Despite efforts to control the use of tobacco, it is still consumed by 852 million people worldwide, according to US researchers.

  • One in 20 hospital beds used to treat smoking-related illnesses

    Updated: 2012-08-17 14:59:00
    One in every 20 hospital beds are occupied by someone with a smoking-related illness, according to new figures.

  • Trial launch of urgently-needed combination treatment for oesophago-gastric cancer

    Updated: 2012-08-17 00:01:00
    Cancer Research UK’s Drug Development Office (DDO), in collaboration with academia and industry, has announced a new trial to open in Oxford. The trial will test an experimental drug from AstraZeneca in patients with advanced oesophago-gastric cancer – a disease for which no well-established standard treatments exist.

  • Trial confirms benefit of 'exciting' new drug for advanced prostate cancer

    Updated: 2012-08-16 12:57:00
    Results of an international clinical trial have confirmed the benefits of enzalutamide, a new treatment for advanced prostate cancer.

  • Antiandrogen Ups Late Prostate Cancer Survival

    Updated: 2012-08-15 23:32:23
    Men with advanced, postchemotherapy prostate cancer had almost a 5-month survival advantage when treated with an androgen receptor-signaling inhibitor, results of a large randomized trial showed.

  • PSA Screening Benefits Fall Short of Predictions

    Updated: 2012-08-15 22:00:00
    Mortality and quality-of-life benefits from prostate cancer screening fell short of estimates among men who participated in a large European screening study, investigators reported.

  • An Aspirin a Day…

    Updated: 2012-08-15 16:24:00
    About Us Sponsored : by CTCA Cancer News Daily Aspirin May Cut Cancer Deaths , Another Study Finds But drug has bleeding risks and shouldn't be used solely to prevent cancer , experts say Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests Cancer Nutrition Diet

  • The Debate Continues, Is IAD or CAD Superior for the Treatment of Men with Castrate Resistant Prostate Cancer?

    Updated: 2012-08-15 03:30:50
    A new randomized study (FinnProstate Study VII) on the merits of intermittent androgen deprivation (IAD) compared to continuous androgen therapy (CAD) contradicts the recent revelations from the last ASCO presentation (Hussain et.al) where the clear conclusion was that CAD was superior to IAD. At the ASCO conference Dr. Hussain’s study concluded that IAD was significantly [...]

  • New Cancer Research UK trial will shed light on risks and benefits of sun exposure

    Updated: 2012-08-15 00:01:00
    Cancer Research UK has today launched a trial investigating the health benefits and risks of spending time in the sun. It is hoped the trial will help solve years of controversy surrounding vitamin D, the 'sunshine vitamin', and how much sun is too much.

  • Exercise can improve quality of life during and after cancer treatment

    Updated: 2012-08-15 00:01:00
    Exercise can improve the quality of life of some cancer patients and survivors, according to two new reviews of the evidence.

  • CRT to license CTx’s FAK inhibitor programmes bringing treatment hope for triple-negative breast cancer

    Updated: 2012-08-14 23:00:00
    Cancer Research Technology, (CRT), the commercial arm of Cancer Research UK, is entering into two licences with Cancer Therapeutics CRC (CTx), an Australian cancer drug and development company, to commercialise CTx's pre-clinical focal adhesion kinase (FAK) inhibitor programmes.

  • 2012 Blue Ribbon Tea

    Updated: 2012-08-14 19:10:15
    The 2012 Blue Ribbon Tea is quickly approaching! Learn more about this upcoming event and how you can participate. Related posts: It’s Prostate Cancer Awareness Month Inspire HER Join the One-in-Six Club

  • Study suggests patients should be screened before receiving vemurafenib

    Updated: 2012-08-13 22:01:00
    Different genetic mistakes driving skin cancer may affect how patients respond to the drug vemurafenib, providing grounds to screen people with melanoma skin cancer before treatment, a new study by Cancer Research UK scientists suggests.

  • Scientists solve key piece of prostate cancer puzzle

    Updated: 2012-08-13 22:00:00
    Cancer Research UK scientists have revealed a completely new route by which male androgen hormones fuel the growth of prostate cancer, raising the prospect that existing drugs could be used to treat the disease.

  • No Reduction in Mortality for Men with Localized Prostate Cancer who had a Prostatectomy

    Updated: 2012-08-13 20:08:04
    In an updated study published in the New England Journal of Medicine men who had a radical prostatectomy did not enjoy the experience of a reduced all-cause mortality or prostate cancer mortality compared with those men who had only observation through several years of follow-up. The subject men had localized prostate cancer often detected by [...]

  • Adding Radiotherapy to ADT Increases Survival for a Man Diagnosed with Locally Advanced Prostate Cancer

    Updated: 2012-08-10 16:37:00
    Men with locally advanced prostate cancer have a better survival chance if they receive radiotherapy along with androgen deprivation therapy (ADT). This data was presented at the recent American Society of Clinical Oncology (ASCO) 2012 conference. Professor Malcom Mason from Whales University discussed a trial he conducted that demonstrated that for a man diagnosed with [...]

  • Smoking sharply increases risk of certain cancers of the immune system and bone marrow

    Updated: 2012-08-10 00:09:00
    Women who smoke increase their risk of developing certain cancers of the blood, immune system, and bone marrow new research shows today (Friday).

  • Drug-PSA Combo May Pinpoint Prostate Cancer

    Updated: 2012-08-09 18:00:00
    The drugs used to treat benign prostatic hyperplasia (BPH) may also help detect some hard-to-find cases of prostate cancer, researchers reported.

  • Variation in GP appointment rules linked to emergency presentations for cancer

    Updated: 2012-08-09 17:17:00
    GP practices that offer a routine GP appointment within 48 hours are less likely to have patients diagnosed with cancer for the first time via an emergency hospital admission, according to new research published by the British Journal of Cancer.

  • Scientists discover how iron levels and a faulty gene cause bowel cancer

    Updated: 2012-08-09 17:00:00
    HIGH LEVELS of iron could raise the risk of bowel cancer by switching on a key pathway in people with faults in a critical anti-cancer gene, according to a study published in Cell Reports.

  • Teen smokers 'heed health warnings' on plain cigarette packs

    Updated: 2012-08-09 01:12:00
    Teenagers who occasionally smoke are more likely to pay attention to health warnings on cigarettes packets that have been stripped of branding, according to a small UK study.

  • Cancer Care De-funds Men from Financial Support!

    Updated: 2012-08-08 17:04:13
    I received a very disturbing notice from Cancer Care about their ability to provide financial support for men with cancer, including men with prostate cancer. As of August 6, 2012 they will not be able to accept applications or provide assistance to men with cancer unless they meet the following criteria: 1- Men diagnosed with [...]

  • Melanoma Can Strike Anyone

    Updated: 2012-08-08 15:37:00
    About Us Sponsored : by CTCA Cancer News Daily Aspirin May Cut Cancer Deaths , Another Study Finds But drug has bleeding risks and shouldn't be used solely to prevent cancer , experts say Read full story Cancer News Categories Breast Cancer News Colorectal Cancer News Gynecologic Cancer News Hematological Cancer News Lung Cancer News Prostate Cancer News Pancreatic Cancer News Other Cancer News Message Board Cancers Bladder Cancer Bone Cancer Brain Cancer Breast Cancer Colon Cancer Esophageal Cancer Gynecological Cancers Kidney Cancer Leukemia Liver Cancer Lung Cancer Melanoma Pancreatic Cancer Prostate Cancer Stomach Cancer Testicular Cancer After Treatment Emotional Support Nutritional Concerns Side Effects Cancer Diagnosis Diagnostic Imaging Lab Tests Other Tests Cancer Nutrition Diet

  • More than 75,000 Cancer Research UK supporters want to ban tobacco branding

    Updated: 2012-08-08 00:01:00
    More than 75,000 people have so far signed up to support Cancer Research UK’s ‘The answer is plain’ campaign as the Department of Health consultation on the future of tobacco packaging closes this Friday.

  • Perhaps Vitamin D & Calcium is Not Good for Men with Advanced Prostate Cancer!

    Updated: 2012-08-07 23:13:58
    Science and good medicine is not always what it seems. We all believe that if something is logical it must be true, but often the most logical assumptions we make do not stand up to good scientific inquiry. Many of us choke on the fact that Provenge extends life while it has no effect on [...]

  • Research points to potentially cheaper targeted cancer treatment

    Updated: 2012-08-07 18:26:00
    Sirolimus, a cheap and widely available drug used to treat transplant patients, is suitable for further testing to treat cancer when combined with grapefruit juice, according to a preliminary clinical trial in the US.

  • Impact of Postoperative PSA Scores on Recurrence and the use of Salvage Therapy on the Risk of Death

    Updated: 2012-08-06 15:43:02
    In a study conducted by Choueiri et al. published in Cancer it was suggested that men who have prostate cancer that was treated by a radical prostatectomy (RP) who then had a long time to a biochemical recurrence (BCR) or a long PSA doubling time after a BCR have no higher overall risk of death [...]

  • Healthy cells around tumours 'help fuel chemotherapy resistance'

    Updated: 2012-08-05 18:00:00
    The damage chemotherapy can cause to the healthy cells around tumours - the so-called 'tumour microenvironment' - could help cancer to develop resistance to treatment, according to a US study.

Current Feed Items | Previous Months Items

Jul 2012 | Jun 2012 | May 2012 | Apr 2012 | Mar 2012 | Feb 2012